Page 95 - Cronos Group News Today

Field Trip Intends to Use the Net Proceeds From the Offering for the Development of the Company’s FT-104 Novel Psychedelic Development Program, the Opening of New Field Trip Health Centers, and for Working Capital and General Corporate Purposes Field Trip Health (OTC:FTRPF) announced that, due to strong demand, it has agreed with a syndicate of underwriters led by Bloom Burton Securities, to increase the size of its previously announced $50,000,015 bought deal offering. Pursuant to the upsiz...

The Global X Cannabis ETF has benefitted from improving investor sentiment as the legalisation of marijuana sales across the US continues.

The company's mixed quarter saw it trounce revenue estimates, but fall short of profitability forecasts.

Full Year Results Consolidated net revenue for the full year reached $46.72 million — up by 97% from the prior year. In 2020, Cronos had an adjusted EBITDA loss of $98.31 million, compared to an EBITDA loss of $48.95 million in 2019. Fourth Quarter Results For the last quarter of 2020, Cronos disclosed a net loss of $111.71 million, which compares to a net income of $61.57 million in the fourth quarter of the prior year. Its adjusted EBITDA for the quarter was a loss of $53.13 million, versus...

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) released Friday its fourth quarter and full-year 2020 financial results with a yearly net loss of $75 million, compared to a net income of $1.1 million in 2019. Full Year Results Consolidated net revenue for the full year reached $46.72 million —... Read More... Dont Miss Any Updates! News Directly in Your Inbox Subscribe to:

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) released Friday its fourth quarter and full-year 2020 financial results with a yearly net loss of $75 million, compared to a net income of $1.1 million in 2019. Full Year Results Consolidated net revenue for the full year reached $46.72 million —... Read More... Dont Miss Any Updates! News Directly in Your Inbox Subscribe to:

The prospect of cannabis legalization in the US is giving the industry a boost, and could fuel a wave of deals.

The Public Sector Pension Investment Board unloaded some marijuana investments the past couple of years while raising its holdings in Aphria and Aurora Cannabis.

Medical Cannabis Extraction Market 18 Medical Cannabis Extraction Market –Industry Trends and Forecast to 2028” focuses on the major drivers and restraints for the key players. These research report also provides Comprehensive analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. Report is a professional and in-depth study on the current state of Industry. With 350 pages, 60 Figures And 220 Tables in it Medical Cannabis Extraction Market  ...

The (Forgotten) Deal Altria Group bought a 45 percent stake in leading cannabinoid company Cronos Group for about $1.8 billion. Altria  also has a warrant that would allow it to increase its stake in Cronos to about 55 percent at a price of $19 per share. It allows Cronos the flexibility to take investments from other companies such as, for example, a big food company. “The proceeds from Altria’s investment will enable us to more quickly expand our global infrastructure and distribution f...